However, after that, she confirmed with the insurance company that coverage for Wegovy would mainly apply to certain conditions, but not for weight loss or obesity only
adult obesity rate has gradually dropped to 36.4% thus far in 2026, a statistically meaningful decline that continues to inversely track with increased usage of GLP-1 medicine nationally
Diabetes 63 (10), 32213229
While innovation benefits patients, research and development investments are often factored into overall pricing strategies
Skipping doses of a GLP-1 RA for a trip is generally not recommended, as it interferes with the development of long-term healthy habits
No, compounded medications are typically cash-pay only and are not covered by most insurance or government plans